Latest filing published 30 Mar 2026 for Insight Molecular Diagnostics Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Andrea S. James in Insight Molecular Diagnostics Inc. Between 2 October 2024 and 26 March 2026, the trades on record add up to 8 filings.
The open-market record is one-sided, with 3 purchases worth €327k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 3 option exercises.
In size, the median ticket on the buying side is €91k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 30 March 2026: a share grant of €40k, in Insight Molecular Diagnostics Inc. The clock since the last published purchase (11 February 2025) now reads 621 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations